만성 B형 간염 및 항바이러스제 내성 B형 간염의 모니터링과 치료 전략
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김태엽 | - |
dc.contributor.author | 손주현 | - |
dc.date.accessioned | 2022-12-21T07:34:01Z | - |
dc.date.available | 2022-12-21T07:34:01Z | - |
dc.date.created | 2022-09-16 | - |
dc.date.issued | 2007-06 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180006 | - |
dc.description.abstract | Clinical management of chronic hepatitis B is rapidly evolving after the recent development of new antiviral drugs. These agents have been shown to be effective in improving virological, biochemical, and histological features in high proportion of the patients with chronic hepatitis B. However, these drugs can not eliminate hepatitis B virus (HBV) directly. It can only suppress HBV replication. Furthermore, the emergence of drug resistant HBV has become problematic according to the long-term use of oral antiviral drugs. Therefore, physicians should be careful in selecting whom to treat, when to start treatment, how long to treat, how to monitor patients before, during and after the treatment, which drug to choose, and how to manage patients with drug resistance. This review will focus on the monitoring and treatment strategy for chronic hepatitis B and drug resistant hepatitis B, quoting some clinical data of recently introduced or promising future drugs. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한소화기학회 | - |
dc.title | 만성 B형 간염 및 항바이러스제 내성 B형 간염의 모니터링과 치료 전략 | - |
dc.title.alternative | Monitoring and treatment strategy for chronic hepatitis B and antiviral resistant hepatitis B | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 손주현 | - |
dc.identifier.scopusid | 2-s2.0-55449108952 | - |
dc.identifier.bibliographicCitation | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, v.49, no.6, pp.346 - 355 | - |
dc.relation.isPartOf | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi | - |
dc.citation.title | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi | - |
dc.citation.volume | 49 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 346 | - |
dc.citation.endPage | 355 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | alanine aminotransferase | - |
dc.subject.keywordPlus | antivirus agent | - |
dc.subject.keywordPlus | hepatitis B(e) antigen | - |
dc.subject.keywordPlus | RNA directed DNA polymerase inhibitor | - |
dc.subject.keywordPlus | antiviral resistance | - |
dc.subject.keywordPlus | blood | - |
dc.subject.keywordPlus | drug effect | - |
dc.subject.keywordPlus | hepatitis B | - |
dc.subject.keywordPlus | Hepatitis B virus | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | virology | - |
dc.subject.keywordPlus | Alanine Transaminase | - |
dc.subject.keywordPlus | Antiviral Agents | - |
dc.subject.keywordPlus | Drug Resistance, Viral | - |
dc.subject.keywordPlus | Hepatitis B e Antigens | - |
dc.subject.keywordPlus | Hepatitis B virus | - |
dc.subject.keywordPlus | Hepatitis B, Chronic | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Reverse Transcriptase Inhibitors | - |
dc.identifier.url | https://www.kjg.or.kr/journal/view.html?uid=3800&vmd=Full | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.